 Jackson Center, Pennsylvania--Newsfile Corp. - June 1, 2021 - Halberd Corp. OTC Pink: HALB announced the filing of a U. S. joint provisional patent application titled, Antibody Conjugated Nanoparticle Assay And Treatment For SARS-CoV-2. The innovation is a result of Halberds Sponsored Research conducted at Arizona State University ASU. The provisional patent application covers technology developed to facilitate conjugation of metallic nanoparticles with antibodies against various bacteria and SARS-CoV-2, for elimination via radio... 